Christoph Zielinski

Researcher Next ID · RN-008087

Researcher · Medicine

Vienna, Austria

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Advanced Breast Cancer Therapies

Cancer Treatment and Pharmacology

HER2/EGFR in Cancer Research

Monoclonal and Polyclonal Antibodies Research

Cancer Genomics and Diagnostics

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer
Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2017.73.6785
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
Annals of Oncology · 2015 · https://doi.org/10.1093/annonc/mdv249
Therapeutic vaccines for cancer: an overview of clinical trials
Nature Reviews Clinical Oncology · 2014 · https://doi.org/10.1038/nrclinonc.2014.111
Prediction of venous thromboembolism in cancer patients
Blood · 2010 · https://doi.org/10.1182/blood-2010-02-270116
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
The Lancet · 2009 · https://doi.org/10.1016/s0140-6736(09)61497-5

No projects listed.